Northrop Grumman Corporation

(New York Stock Exchange)
Back to all articles
Bullish +65

Northrop Grumman Shares Up 28% YTD With Its Biggest Upside Not Yet in Guidance - 24/7 Wall St.

AI-generated analysis

πŸ“ˆ Northrop Grumman shares are up 28% YTD, trading above the $675 analyst consensus target at approximately $735.18.

βœ… A signed Air Force contract now backs CEO Kathy Warden's Q4 promise to accelerate B-21 production funding.

πŸ’° Q4 2025 revenue hit a record $11.7 billion, representing a 10% year-over-year increase.

πŸ“¦ The company maintains a massive record backlog of $95.7 billion across its portfolio.

πŸ’΅ Free cash flow surged to $3.3 billion in Q4 2025, marking a 26% increase from the prior year.

πŸš€ The Aeronautics Systems business alone grew by 18% during the fourth quarter of 2025.

⏳ B-21 financial impact is expected to ramp meaningfully in 2027 and 2028, currently unpriced in guidance.

πŸ›‘οΈ CEO Kathy Warden cites the current defense spending environment as the most robust she has seen in her career.

⚠️ The Sentinel ICBM program faces risks including a slipped initial operating capability date to 2033.

πŸ“‰ Short interest in NOC has risen 19% recently, though it remains below the defense sector average.

Bullish Signals
  • Shares are up 28% year-to-date and trading above analyst consensus targets, indicating strong market confidence in execution.
  • The B-21 acceleration agreement converts previous verbal promises into a signed commitment with minimal 2026 financial impact but significant future ramp potential.
  • Q4 2025 revenue reached a record $11.7 billion, demonstrating consistent top-line growth and market demand.
  • Free cash flow increased by 26% to $3.3 billion, highlighting strong operational efficiency and liquidity generation.
  • The Aeronautics Systems business grew 18% in Q4, serving as a primary engine for overall company performance.
  • CEO Kathy Warden describes the defense spending environment as the most robust she has witnessed in her entire career.
  • Northrop Grumman maintains a record backlog of $95.7 billion, providing high visibility into future revenue streams.
Risk Factors
  • The Sentinel ICBM program faces significant schedule risks with initial operating capability slipping to 2033 following a Nunn-McCurdy cost breach.
  • The B-21 production ramp is not yet included in 2026 guidance, creating uncertainty around near-term financial quantification of the new contract.
  • Recent short interest has risen 19%, suggesting some investors remain cautious despite the overall bullish trend.
  • The company previously suffered a $477M loss provision on the B-21 program, which temporarily shook investor confidence.
Full Analysis
Northrop Grumman (NOC) shares have surged 28% year-to-date, trading above analyst consensus targets around $735.18 despite a recent $477M loss provision related to the B-21 program. The company has successfully converted previous earnings-call promises into a signed Air Force contract for accelerating B-21 production, validating CEO Kathy Warden's optimism regarding funding approved in the reconciliation bill. Financial performance remains robust with Q4 2025 revenue reaching a record $11.7 billion, up 10% year-over-year. The company boasts a massive backlog of $95.7 billion and generated $3.3 billion in free cash flow, a 26% increase from the prior year. Specifically, the Aeronautics Systems business grew by 18% in Q4, contributing significantly to overall strength. Management highlights three key bullish drivers: the funded B-21 acceleration deal representing unpriced upside for 2026-2028, a defense spending environment described as the most robust in CEO Warden's career, and strong social sentiment scores. However, investors remain cautious about the Sentinel ICBM program, which faces schedule slips to an initial operating capability of 2033 following a Nunn-McCurdy cost breach.